ELAVL1 and breast carcinoma: On the one hand, our data suggest that the mechanism by which eltrombopag inhibits the migration and invasion of breast cancer cells may be due to the HuR-mediated reduction of Snail, Cox-2, and Vegf-c mRNA stability, resulting in reduced protein expression.